decisionhealth Newsletters, Part B News - 2012 Issue 4 (April)
Top-billed drug codes to see less pay in second quarter ASP drug changes
Subscribe or sign in to view the full article.
Article Overview
This article covers CMS’s second-quarter average sales price (ASP) update for Medicare Part B drugs and highlights how the changes affect frequently billed drug codes. It is relevant to coders, billing staff, reimbursement analysts, and specialty practices that report and track drug payment changes. The discussion focuses on broad pricing trends, volume-related impacts, and examples of notable increases and decreases in the ASP file.
Why This Topic Matters
Payment for commonly billed drugs can shift when CMS updates ASP-based pricing, affecting revenue planning and claims reimbursement. Readers use this kind of update to understand which drug categories are seeing broader market movement and to stay current with quarterly Medicare Part B pricing changes.
What You Will Learn
- How CMS quarterly ASP updates can affect Medicare Part B drug reimbursement
- The general trend of price changes among high-volume drug codes
- Which kinds of drug payment changes are discussed in the article
- Why quarterly ASP updates matter for billing and reimbursement monitoring
Who Should Read This
- Medical coders
- Billing specialists
- Reimbursement analysts
- Infusion and oncology practices
- Medicare Part B providers
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com